Fluorescence Polarization Binding Assay for Aspergillus fumigatus Virulence Factor UDP-Galactopyranose Mutase

Jun Qi1, Michelle Oppenheimer, Pablo Sobrado

  • 1Department of Biochemistry, Virginia Tech, Blacksburg, VA 26061, USA.

Enzyme Research
|August 31, 2011
PubMed

Insights

Researchers developed a fluorescence polarization assay to find new drugs targeting Aspergillus fumigatus. The assay uses fluorescently labeled UDP analogs to inhibit UDP-galactopyranose mutase, crucial for fungal cell wall integrity and virulence.

Area of Science:

  • Biochemistry
  • Mycology
  • Medicinal Chemistry

Background:

  • Aspergillus fumigatus causes life-threatening lung infections in immunocompromised individuals.
  • Galactofuranose (Galf) in the fungal cell wall is vital for A. fumigatus virulence.
  • UDP-galactopyranose mutase (UGM) is essential for synthesizing Galf.

Purpose of the Study:

  • To develop a fluorescence polarization (FP) binding assay for A. fumigatus UGM (AfUGM).
  • To identify high-affinity fluorescently labeled UDP analogs for AfUGM inhibition.
  • To establish a screening method for novel anti-fungal therapeutics.

Main Methods:

  • Synthesis of fluorescently labeled UDP analogs.
  • Development and validation of an FP binding assay for AfUGM.
  • Determination of binding affinities (K(d) values) using the FP assay.

Main Results:

  • TAMRA-labeled UDP analogs showed high-affinity binding to AfUGM (K(d) values of 2.6-3.0 μM).
  • Binding affinity was significantly higher compared to fluorescein-labeled analogs.
  • The FP assay demonstrated excellent performance with a Z' factor of 0.79 and good DMSO tolerance.

Conclusions:

  • A validated FP assay for AfUGM was established.
  • Fluorescently labeled UDP analogs, particularly TAMRA conjugates, are effective tools for studying AfUGM.
  • This assay provides a foundation for discovering new drugs targeting A. fumigatus infections.

Related Concept Videos